c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Pelthos Therapeutics (PTHS) Reports 114% Revenue Growth in Q3 2026, Expands Access for Zelsuvmi
GuruFocus | Nov 12, 2026 3:59 PM EST
Related Stocks: PTHS ,
Read original article